Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
768K
-
Number of holders
-
24
-
Total 13F shares, excl. options
-
3.38M
-
Shares change
-
+1.78M
-
Total reported value, excl. options
-
$1.21M
-
Value change
-
+$585K
-
Number of buys
-
10
-
Number of sells
-
-8
-
Price
-
$0.36
Significant Holders of Aethlon Medical, Inc. - Common Stock, $0.001 par value per share (AEMD) as of Q1 2025
28 filings reported holding AEMD - Aethlon Medical, Inc. - Common Stock, $0.001 par value per share as of Q1 2025.
Aethlon Medical, Inc. - Common Stock, $0.001 par value per share (AEMD) has 24 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.38M shares
.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (1.43M shares), Ikarian Capital, LLC (1.23M shares), BOOTHBAY FUND MANAGEMENT, LLC (359K shares), GEODE CAPITAL MANAGEMENT, LLC (124K shares), UBS Group AG (66.7K shares), TWO SIGMA SECURITIES, LLC (31.3K shares), Allegiance Financial Group Advisory Services LLC (30K shares), TWO SIGMA INVESTMENTS, LP (22.7K shares), VANGUARD GROUP INC (21.2K shares), and HRT FINANCIAL LP (19.9K shares).
This table shows the top 24 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.